S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

ANIP ANI Pharmaceuticals Inc

57.23

-2.16 (-3.64%)

30 Nov 2024 - Closed

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/26/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Nikhil S Lalwani

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals (NASDAQ:ANIP)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more ANI Pharmaceuticals Charts.

ANI Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 28 November 2024 (2 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 27 November 2024 (3 days ago) • Edgar (US Regulatory)

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference
Wednesday 27 November 2024 (4 days ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 20 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 19 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Saturday 9 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 November 2024 (3 weeks ago) • Edgar (US Regulatory)

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance
Friday 8 November 2024 (3 weeks ago) • GlobeNewswire Inc.

ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November
Tuesday 5 November 2024 (4 weeks ago) • GlobeNewswire Inc.

More ANI Pharmaceuticals Inc News Articles

JP Morgan Chase

Gold vs US Dollar

Westpac Banking

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions